📄 Direct examination of William Shields — Thursday, June 22, 1995
Address:
C:\DEPT103\CRIMINAL\1995\JUN\22\DIRECT-EXAMINATION-OF-WILLIAM-.DOC
TRIAL
▲ Day 101 of 167

Direct examination of William Shields

Witness: Dr. William Shields
Examiner: George Clarke
Called by: Prosecution • Date: Thursday, June 22, 1995 • Utterances: 250
Defense expert Dr. Renee Shields, a population geneticist and biology professor at SUNY Syracuse, testified about the proper statistical method for analyzing mixed DNA stains. She argued that Dr. Weir's method for computing mixture statistics deviates from the National Research Council's recommendations, makes assumptions beyond the genetic data, and presents numbers biased against the defendant. She also noted that Dr. Weir's framing of likelihood ratios for 'contact vs. no contact' hypotheses omits critical factors like contamination and error rates.
1 THE COURT:

Mr. Thompson.

DIRECT EXAMINATION BY MR. THOMPSON

2 MR. THOMPSON:

Okay. Good afternoon, Dr. Shields. Dr. Shields, did you bring with you a curriculum vitae--

3 DR. SHIELDS:

Yes, I did.

4 MR. THOMPSON:

--on your educational background?

5 MR. THOMPSON:

Your Honor, may I approach and give the Court a copy?

6 THE COURT:

You may.

7 MR. THOMPSON:

And I suppose we should have this marked as the next in--Defense next in order, your Honor.

8 THE COURT:

All right. As soon as I get Mrs. Robertson back. Proceed.

9 MR. THOMPSON:

Okay. Okay. Dr. Shields, could you describe your educational background?

10 DR. SHIELDS:

I have an AB in biology from records university and an MS and a Ph.D. in zoology from the Ohio State University.

11 MR. THOMPSON:

And what is your current position?

12 DR. SHIELDS:

I'm a Professor of Biology at the State University of New York, College of Environmental Science and Forestry in Syracuse.

13 MR. THOMPSON:

Okay. And I see on your vitae you list some previous positions that you've held, among them distinguished scholar and residence at Northern Arizona University. Can you describe what that position was?

14 DR. SHIELDS:

That wasn't a previous position. That was an endowed share to allow for people to visit during sabbatical. So I had a sabbatical year that year in 1986, `87 and spent a year in Arizona. In fact, that's where I started doing molecular genetic techniques.

15 MR. THOMPSON:

Okay. All right. Can you describe for us generally what your areas of research are?

16 DR. SHIELDS:

Yes, I can. Since graduate school, about half of the research I've been doing has been in the area of behavioral ecology, primarily with birds. The other half of the research that I do is about evolutionary biology, and in particular, the evolution of population structure and how population structure influences evolution.

17 MR. THOMPSON:

Okay. Now, this work in this second area, evolutionary biology, does this include research and publications in the field of population genetics?

18 DR. SHIELDS:

Yes, it does.

19 MR. THOMPSON:

Have you published peer review articles in the field of population genetics?

20 DR. SHIELDS:

Yes. I published a book and--which is peer reviewed and a number of articles as well.

21 MR. THOMPSON:

Have you also published in the field of statistics?

22 DR. SHIELDS:

I have published papers that are statistical in nature and in the journals where statistics would be.

23 MR. THOMPSON:

Okay. Now, have you published any work relevant to the use of statistics in connection with DNA evidence?

24 DR. SHIELDS:

I've published one paper which was not peer reviewed in a proceedings of a Promega Conference that's directly about the use of statistics in forensic DNA typing, and then I've published a number of papers in parts of the book where relevant ideas, ideas that are relevant to understanding how to do forensic DNA typing, profile frequencies are presented.

25 MR. THOMPSON:

What teaching experience do you have that's relevant to the fields of statistics or population genetics?

26 DR. SHIELDS:

Well, I've taught courses. Well, probably three different ones. I've taught courses in--that have a large genetic component, primarily conversation biology and conversation genetics where one looks at how population genetics influences the conservation of rare and endangered species. I've also taught courses in statistical inference, graduate courses.

27 MR. THOMPSON:

Okay. Now, do you have a laboratory that you work in at Syracuse?

28 DR. SHIELDS:

Yes, I do.

29 MR. THOMPSON:

And what is the nature of the laboratory work that you--that goes on in your lab?

30 DR. SHIELDS:

The laboratory is set up to do what we call field research on genetic variation. We look at a variety of organisms and use three major tools to look at how they vary in nature. We use protein electrophoresis which has been mentioned, we use RFLP DNA typing and we also use PCR.

31 MR. THOMPSON:

Okay. And you say "We." Do you supervise other people in your laboratory?

32 DR. SHIELDS:

Yes. I have graduate students.

33 MR. THOMPSON:

Okay. Now, are you familiar with the methods used for forensic DNA testing?

34 DR. SHIELDS:

Yes, I am.

35 MR. THOMPSON:

And how did you become involved in the area of forensic DNA testing?

36 DR. SHIELDS:

In about 1990, an attorney in Syracuse, New York asked me to look at some data involved in a criminal case, and that was my initial involvement. As a result of that case, I became involved in his case, and I've continued to occasionally look at a variety of data that are relevant to forensic proceedings.

37 MR. THOMPSON:

Uh-huh. Are you familiar with the methods used by laboratories such as Cellmark diagnostics and DOJ?

38 DR. SHIELDS:

Yes, I am.

39 MR. THOMPSON:

Have you visited any forensic laboratories to observe how they do their work?

40 DR. SHIELDS:

Yes, I have.

41 MR. THOMPSON:

Which laboratories have you visited?

42 DR. SHIELDS:

I've visited Cellmark. I have visited the Department of Orange County's crime lab. I have visited the--that's about it.

43 MR. THOMPSON:

Okay. And have you studied--

44 DR. SHIELDS:

Oh, I visited the FBI's Quantico laboratory as well.

45 MR. THOMPSON:

Okay.

46 DR. SHIELDS:

But they don't do their case work there. That's where they do the research underlying the case work.

47 MR. THOMPSON:

The FBI's research facility where they develop the techniques?

48 DR. SHIELDS:

That's correct.

49 MR. THOMPSON:

Okay. And while there, did you review scientific data produced by the FBI?

50 DR. SHIELDS:

Yes, I did.

51 MR. THOMPSON:

Okay. And have you studied the protocols developed by the various forensic laboratories that do DNA testing?

52 DR. SHIELDS:

Yes. Many more than I visited.

53 MR. THOMPSON:

Okay. Have you done studies of the databases developed by forensic laboratories?

54 DR. SHIELDS:

Yes, I have.

55 MR. THOMPSON:

What sort of studies have you done?

56 DR. SHIELDS:

I've done similar studies back in 1990, `91 to the sorts that Dr. Weir mentioned earlier, looking at the data that are produced in--by the forensic laboratories for difference races and ethnic groups and different geographical regions to examine the issues of independence. I've done that for 40, 50 labs from around the world.

57 MR. THOMPSON:

Okay. And does this work have to do with assessing the validity of statistical inferences drawn from forensic DNA evidence?

58 DR. SHIELDS:

Yes.

59 MR. THOMPSON:

Okay. Do people who do forensic testing call on you for advice?

60 DR. SHIELDS:

Sometimes.

61 MR. THOMPSON:

Can you describe some of those times?

62 DR. SHIELDS:

Well, I've been asked to present my ideas about some of the potentials and problems with--associated with forensic DNA typing, in particular, the statistical aspects by Promega in a human identification conference a number of years ago, by the California association of criminalists, again, a number of years ago at a meeting at bass lake.

63 MR. THOMPSON:

Is this the same California association of criminalists that we've heard testimony about in this case from Mr. Fung and other witnesses?

64 DR. SHIELDS:

Yes.

65 MR. THOMPSON:

Okay. When you attended these conferences, did you meet with people from the LAPD crime lab?

66 DR. SHIELDS:

Yes.

67 MR. THOMPSON:

Please go on about the other--

68 DR. SHIELDS:

I've also been asked to in essence do short courses, sometimes a little longer than short, but short courses and other kinds of courses about forensic DNA typing, and again, particularly, the statistics with a variety of legal organizations; for example, public defender's office in Maryland, public defender's office in New Hampshire, the public defender's office in Massachusetts, also, the Bar Association of Tompkins County in New York, so that it had Prosecutors, Judges and Defenders, and I've been asked to engage in debate to explicate these issues, for example, at the University of Iowa with scientists associated with the Royal Canadian Mounted Police.

69 MR. THOMPSON:

Have you been asked by any crime labs to consult with them on how to set up their databases?

70 DR. SHIELDS:

Yes, I have. Fairly recently, I've become involved with the Monroe County crime lab, that's Rochester, New York, in an attempt to develop databases that they can use with their PCR techniques.

71 MR. THOMPSON:

Now, one other question about your laboratory. You mentioned a lot of the statistical work. In your laboratory, do you also do work in molecular biology?

72 DR. SHIELDS:

My students do. I don't do actual molecular biology for my own research, but I in essence teach them and assist them in interpreting their molecular work.

73 MR. THOMPSON:

So--and would this include, for example, RFLP analysis?

74 DR. SHIELDS:

Yes, it does.

75 MR. THOMPSON:

In your laboratory, do people under your supervision do PCR work?

76 DR. SHIELDS:

Yes, they do.

77 MR. THOMPSON:

Okay. Now, have you been called to testify as an expert witness concerning statistical inferences in forensic DNA evidence cases?

78 DR. SHIELDS:

Yes, I have.

79 MR. THOMPSON:

About how many times have you testified as an expert witness?

80 DR. SHIELDS:

In about 60 different cases. And those cases sometimes would include hearings and/or trials, sometimes both.

81 MR. THOMPSON:

Now, do you testify only for the Defense or are you willing to testify or have you testified for both Prosecution and Defense?

82 DR. SHIELDS:

I've testified for both.

83 MR. THOMPSON:

Okay. Have you ever been asked to testify as an expert witness by the Los Angeles County District Attorney's office?

84 DR. SHIELDS:

Yes.

85 MR. THOMPSON:

Okay. And how did it happen that you were contacted by the Los Angeles County District Attorney's office and asked to be an expert witness for them?

86 DR. SHIELDS:

An assistant District Attorney, whose name I do not remember, called and asked if I would be interested, and he said he was calling at the request of another assistant District Attorney.

87 MR. THOMPSON:

And who was that?

88 DR. SHIELDS:

Miss Kahn.

89 MR. THOMPSON:

And this is Lisa Kahn, who is sitting to my right; is that right?

90 DR. SHIELDS:

Pardon?

91 MR. THOMPSON:

You're referring to Miss Kahn, who is sitting to my right?

92 DR. SHIELDS:

Yes.

93 MR. THOMPSON:

Okay. Now, Dr. Shields, are you familiar with the National Research Council's report titled "DNA technology and forensic science"?

94 DR. SHIELDS:

Yes, I am.

95 MR. THOMPSON:

And do you consider this an authoritative source of scientific information about forensic DNA testing?

96 MR. CLARKE:

Objection. No foundation.

97 THE COURT:

Overruled.

98 DR. SHIELDS:

I'm sorry. Would you repeat the question?

99 MR. THOMPSON:

Do you consider this an authoritative source of scientific information about forensic DNA testing?

100 DR. SHIELDS:

Yes.

101 MR. THOMPSON:

Okay. Now, at page 59 of the NRC report, there's a statement that we've been talking about concerning the way--concerning what statistics should be computed in connection with mixed DNA samples. Are you familiar with that statement?

102 DR. SHIELDS:

Yes, I am.

103 MR. THOMPSON:

And do you agree with that statement?

104 DR. SHIELDS:

Are we talking about the statement that's the last sentence in the third paragraph, fourth paragraph?

105 MR. THOMPSON:

To be clear, let me read the statement. The statement says: "If a suspect's pattern is found within the mixed pattern, the appropriate frequency to assign to such a match is the sum of the frequencies of all genotypes that are contained within, i.e., that are a subset of the mixed pattern." Now, that's the statement you're familiar with?

106 DR. SHIELDS:

Yes.

107 MR. THOMPSON:

And do you agree with that statement?

108 DR. SHIELDS:

Yes, I do.

109 MR. THOMPSON:

Okay. Now, I would like to have you take a look at the exhibit that's been marked Prosecution no. 410. And I don't know if I can put that on the elmo now.

110 THE COURT:

Do you have a copy of that in front of you?

111 DR. SHIELDS:

Yes, I do, your Honor.

112 THE COURT:

No. I'm talking about the exhibit.

113 DR. SHIELDS:

Oh, no.

114 THE COURT:

We don't need the elmo for this purpose, counsel.

115 MR. THOMPSON:

All right. Okay.

116 DR. SHIELDS:

Actually, I'm sorry, your Honor. I don't. I didn't know you were talking about the exhibit.

117 THE COURT:

All right. Mr. Thompson, do you have a copy of that--

118 MR. THOMPSON:

I do, your Honor. Just a moment.

119 THE COURT:

All right. Go ahead, put it on the elmo, save us time.

120 MR. THOMPSON:

Okay.

121 THE COURT:

All right. That's People's exhibit 410.

122 MR. THOMPSON:

Okay. Now, Dr. Shields, has this chart--does this chart show computations that have been done in accordance with the recommendations of the National Research Council concerning mixtures?

123 DR. SHIELDS:

Yes.

124 MR. THOMPSON:

Okay. Why is it necessary to compute statistics for mixed DNA stains in a manner that's different for--from the way statistics are computed for an unmixed stain, stain from a single person?

125 DR. SHIELDS:

Because there's a different set of evidence that needs to be addressed. In one case, they're--in what we call a single stain, we will see evidence that's consistent with a single stain and no positive evidence of a mixture. In other words, we can assume that it's a single person and not have any evidence that's against that or any evidence that would suggest otherwise. When you have a mixture, you know that there is more than one person involved in that piece of evidence. But what you don't know, there's no positive evidence that it's two, three, four or five.

126 MR. THOMPSON:

Or more?

127 DR. SHIELDS:

Or any number. There is no evidence based on simply the mixture that you see in a stain of how many people contributed to that.

128 MR. THOMPSON:

And how does that uncertainty about number of contributors affect the statistic that should be presented to characterize the value of a finding of consistency with a mixture?

129 DR. SHIELDS:

Well, that will depend on the question that you're attempting to address and what you're trying to present to a jury. If what you're trying to do with any trier of fact or to a student, it doesn't matter who the audience is, if what you're trying to do is get a flavor for how common or rare a match would be, which is presumably what's going on, then the question becomes, how many individuals in the random population or the population of interest in another way would be likely to be if they were taken off the street and typed declared potential contributors to that mixed stain. And that's a way of providing a weighting to that evidence without any assumptions.

130 MR. THOMPSON:

Does the National Research Council's method address the question that you just posed?

131 DR. SHIELDS:

Yes, it does.

132 MR. THOMPSON:

Okay. Have you reviewed Dr. Weir's method for computing the frequencies in connection with mixed stains?

133 DR. SHIELDS:

Yes, I have.

134 MR. THOMPSON:

All right. And Dr. Weir in fact prepared a series of reports; did he not?

135 DR. SHIELDS:

Yes, he did.

136 MR. THOMPSON:

Okay. Have you reviewed all of them?

137 DR. SHIELDS:

I'm not sure.

138 MR. THOMPSON:

Well, let's--

139 DR. SHIELDS:

I've reviewed three and some addendum.

140 MR. THOMPSON:

Okay. Let's limit our discussion to his report of--his most recent report, which is the report of Tuesday. No. Wait a minute.

141 DR. SHIELDS:

No. I think it's--

142 MR. THOMPSON:

The report of yesterday. Okay. We'll limit our comments to his diversion yesterday. Have you reviewed that document?

143 DR. SHIELDS:

Yes, I have.

144 MR. THOMPSON:

Does the method Dr. Weir recommends for computing statistics in connection with mixtures comply with the National Research Council's recommendations?

145 MR. CLARKE:

Objection. No foundation.

146 THE COURT:

Overruled.

147 DR. SHIELDS:

No.

148 MR. THOMPSON:

And why not? In what way does it fail to comply with the National Research Council's method?

149 DR. SHIELDS:

The National Research Council is very clear and unequivocal about how this should be done. It says to sum the frequencies of all genotypes that are found in the mixture. Genotypes are individuals. The frequencies of all of the individuals whose genotypes allow them to be potential contributors to that mixture is the only way that one can produce a frequency as suggested by that sentence.

150 MR. THOMPSON:

Okay.

151 DR. SHIELDS:

In contrast, Dr. Weir's methodology produces a summation of the frequency of pairs of individuals. Rather than simply summing genotypes, it sums probabilities of pairs of individuals.

152 MR. THOMPSON:

In your opinion, is Dr. Weir's method an appropriate way to characterize the value of mixture evidence in a case such as this one?

153 MR. CLARKE:

Objection. No foundation.

154 THE COURT:

Overruled.

155 DR. SHIELDS:

No.

156 MR. THOMPSON:

And why not?

157 DR. SHIELDS:

Because it makes assumptions that go beyond the genetic evidence in my opinion. The genetic evidence of a mixture only allows one to say that one or more individuals contributed to that. It doesn't tell you who. If one assumes that one knows who produced a mixture, one is no longer doing a test of a hypothesis. One is just validating one's initial assumption. So in essence, I don't believe it's correct to assume that you know anything about the number of contributors as a geneticist looking at the data. I think it's appropriate to provide a frequency with which individuals could possibly contribute to the mixture. In contrast, Dr. Weir's method is to ask the question, would these known individuals--what's the probability of these known individuals having contributed to this evidence sample. What the NRCRI would say is, what is the probability of any individuals that could possibly--what's the frequency of, not what's the probability of, but what's the frequency of any individuals that could--and that "Could" is an important word--contribute or could have contributed to this evidence.

158 MR. THOMPSON:

In your opinion, would other scientists in the field of statistics and population geneticists accept Dr. Weir's approach for characterizing mixtures?

159 DR. SHIELDS:

I'm sure--

160 MR. CLARKE:

Objection. I'm sorry. Assumes facts not in evidence, calls for speculation.

161 THE COURT:

Overruled.

162 DR. SHIELDS:

I'm sure that many would.

163 MR. THOMPSON:

And do you think some would not?

164 DR. SHIELDS:

I'm sure that many would not.

165 MR. THOMPSON:

Okay. All right. So--and what about the National Research Council's method? What do you think would be the distribution of scientific opinion about that method?

166 MR. CLARKE:

Same objection.

167 THE COURT:

Overruled.

168 DR. SHIELDS:

I'm sure some would agree and some would disagree. We have one of each here.

169 MR. THOMPSON:

So would it be fair to say that this--this issue of how to compute statistics in connection with mixtures is an issue in controversy in the scientific community?

170 DR. SHIELDS:

It's not really been addressed. So I'm not sure how you could call it a controversy yet.

171 MR. THOMPSON:

Okay. And why is that? Based on your experience, Dr. Shields, in testifying in a number of cases, why is it that this issue of how to compute statistics on mixtures hasn't--hasn't come up before?

172 DR. SHIELDS:

Well, it has come up before. I've been involved in a couple of cases where it's come up. But it doesn't happen frequently enough I think that people have sat down and thought about it except that they did present a way of doing it that's without assumption.

173 MR. THOMPSON:

Okay. So is this--is this an issue that has been discussed extensively in the scientific community or is it an issue that's just emerging as a topic of discussion?

174 DR. SHIELDS:

I think I would say it's emerging.

175 MR. THOMPSON:

Okay. At this point, is there, in your opinion, any consensus in the scientific community about the right way to compute statistics in connection with mixtures?

176 MR. CLARKE:

Objection. Irrelevant.

177 THE COURT:

Overruled.

178 DR. SHIELDS:

I'm sorry. What was that?

179 MR. THOMPSON:

Is there any consensus about the right way to compute statistics in connection with mixtures?

180 DR. SHIELDS:

I'm not sure what "Consensus" means. I don't think so. I mean I--if "Consensus" means everybody sort of agrees, no.

181 MR. THOMPSON:

Okay. Which--which method--as between Dr. Weir's method and the NRC method, which method is the most conservative method in terms of making the fewest assumptions?

182 DR. SHIELDS:

The fewest assumptions? The NRC's method makes no assumptions that are not there in the genetics.

183 MR. THOMPSON:

Okay. And do you think it's bad to make the assumptions that Dr. Weir was making in doing his calculations?

184 DR. SHIELDS:

I wouldn't. I don't think it's good. I'm not sure if "Bad" is the right word for it. I think--I don't think it's--it presents the evidence in the light that's the best characterization of that evidence for--from the genetics.

185 MR. THOMPSON:

Okay. All right. Now, did you understand Dr. Weir to say that the frequencies that he was computing were likelihood ratios?

186 DR. SHIELDS:

Yes.

187 MR. THOMPSON:

Okay. And what is a likelihood ratio?

188 DR. SHIELDS:

A likelihood ratio is in essence just the ratio of two probabilities. And by doing a ratio of two probabilities, one can come up with some feeling for how much more likely one of those hypotheses is versus a second, and it's the probabilities associated with two hypotheses.

189 MR. THOMPSON:

Okay. Now, does a likelihood ratio--what's the purpose of a likelihood ratio in the field of statistics? What is it used for?

190 DR. SHIELDS:

It can be used for lots of different things. But the notion is that you're trying to get a field for how much more likely one proposed set of events is relative to another proposed set of events to explain the same sort of outcome.

191 MR. THOMPSON:

Do you think that Dr. Weir's statistics, that is statistics computed according to his method, are an appropriate likelihood ratio for characterizing the value of mixture evidence in this case?

192 DR. SHIELDS:

No.

193 MR. THOMPSON:

And why not?

194 DR. SHIELDS:

Well, there's actually two reasons. One has to do with the fact that, first of all, they're not likelihood ratios unless one makes an assumption. The frequencies as they're presented for single stains are likelihood ratios if one assumes that there is a known individual. And that's--that can done if you have a known sample, for example, if there's just one individual contributing that stain. You can also do that I think legitimately if you have no extra bands to make an assumption that--to show you that that assumption is absolutely false, that there are in fact more than one contributor to a particular piece of evidence. So if one assumes that there is one individual and they match at each and every band, then the numerator in the likelihood ratio becomes 1. And when you multiply 1 by the frequency, the answer is the frequency.

So the frequency and the likelihood ratio are arithmetically equivalent. But that's based on that 1, and it doesn't have to be 1, the numerator doesn't have to be 1. If you have no knowledge of what the likelihood is, that it was two individuals that contributed a stain or whether it was these two individuals that might have contributed the stain, if you're not using those hypotheses, you can still present the frequency, but it's no longer part of a likelihood ratio. It's simply the frequency of the genetic profile in the populations represented by the databases sampled.

195 MR. THOMPSON:

Okay. And so are you telling us then that the frequencies as computed by Dr. Weir would not be an appropriate likelihood ratio unless a number of assumptions are made?

196 DR. SHIELDS:

Yes. That's just the assumptions for the numerator. There are also assumptions for the denominator.

197 MR. THOMPSON:

And do you think that the assumptions that are required in order for Dr. Weir's frequencies to be treated as a likelihood ratio are appropriate assumptions for an expert witness to make in a criminal case?

198 MR. CLARKE:

Objection. No foundation, irrelevant.

199 THE COURT:

Overruled.

200 DR. SHIELDS:

Would you please repeat it?

201 MR. THOMPSON:

Do you think that the assumptions that would be necessary in order for Dr. Weir's frequencies to be treated as a likelihood ratio are appropriate assumptions for an expert witness to make in a criminal case?

202 DR. SHIELDS:

If--I don't believe they're appropriate for a genetics expert witness to make because a genetics expert is, in my opinion, intended to be presenting information that stems from the genetic data that are associated with that case and only the genetic data.

203 MR. THOMPSON:

And would Dr. Weir's assumptions require the expert to go beyond the genetic data?

204 DR. SHIELDS:

Yes.

205 MR. THOMPSON:

All right. I see in Dr. Weir's report that when he computes likelihood ratios, the likelihood ratio purports to characterize the probability of the evidence under two different hypotheses. Did you see that section?

206 DR. SHIELDS:

Yes, I did.

207 MR. THOMPSON:

And the two hypotheses are that the particular individual had contact with the scene or did not have contact with the scene.

208 DR. SHIELDS:

That's correct.

209 MR. THOMPSON:

Is that correct? Now, do you believe that that is a legitimate way to frame competing hypotheses that are to be tested by genetic data?

210 DR. SHIELDS:

No, because there are non-genetic influences that will change those probabilities.

211 MR. THOMPSON:

Okay. And so if one--if one took the position that frequencies computed from genetic data provided a likelihood ratio for distinguishing those hypotheses, would one be leaving out any important factors?

212 DR. SHIELDS:

Yes.

213 MR. THOMPSON:

What sort of factors would one be leaving out?

214 DR. SHIELDS:

Well, since that what goes into the likelihood ratio here is the probability of this profile given the database information, the frequencies of the variance in a database, it does not address the questions of the likelihood of getting a positive result evidence with a particular profile that's associated with errors of a variety of kinds, cross-contamination that can occur for a variety of reasons, and it also doesn't--all it does is the coincidental match, the probability that someone other than the individual in question might have left the evidence.

215 MR. THOMPSON:

Would it be scientifically valid to leave out those other variables you mentioned when presenting a likelihood ratio which purported to show the relative likelihood of the evidence under the hypothesis contact and no contact?

216 DR. SHIELDS:

In my opinion, no.

217 MR. THOMPSON:

Okay. Would it be biased to present such numbers and to claim that they were a likelihood ratio for the hypothesis contact versus no contact?

218 DR. SHIELDS:

Those two--with that set of words, contact and no contact, yes, I think they are.

KEY QUOTE
219 MR. THOMPSON:

And would it be biased for or against the Defendant in the case?

220 DR. SHIELDS:

Against.

221 MR. THOMPSON:

Okay. Do you think that the assumptions that you've discussed that underlie Dr. Weir's analysis are easy assumptions for people to understand?

222 DR. SHIELDS:

I--no, they're not.

223 MR. THOMPSON:

You've--based on your experience in teaching statistics and genetics to students, would it be easy to explain what's wrong with Dr. Weir's assumptions?

224 DR. SHIELDS:

You use the wrong "Word" and--

225 MR. THOMPSON:

Well, would it be--would it--let me withdraw the question and rephrase it. Would it be easy to explain the nature of the assumptions that Dr. Weir is making?

226 DR. SHIELDS:

In some senses, yes. In other senses, no.

227 MR. THOMPSON:

Okay. Could you explain a little more?

228 DR. SHIELDS:

I think it shows up more in what happens in the results of Dr. Weir's assumptions and analysis where you end up with a set of what he calls frequencies, but I think they are probabilities associated with different explicit pairs of individuals of different ethnic backgrounds associated with different databases and, therefore, different frequencies so that you end up with instead of a number that gives someone a flavor for how likely it is that anybody might contribute to this mixed stain which is a single number, you have a set of numbers that can range from 1 in 7 to 1 in 17,000. And how one interprets that, I think it's open to individuals to look and say, okay, the 1 in 7 is the biggest number, and so that makes that the likeliest trio, and that trio may have very little relationship to anything that's going on in the case or in any case. It's precise, but I think it can mislead.

229 MR. THOMPSON:

Okay. Now, let me direct your attention to the chart that's sitting just to your left. It's the Prosecution's chart labeled "Results of DNA analysis, Bronco automobile." Have you seen that chart before?

230 DR. SHIELDS:

Yes, I have.

231 MR. THOMPSON:

Okay. Now, in the column on the far right, that column is headed with a term "Frequency," and in some of the boxes below there, there are certain numbers. Now, do all the numbers that are presented in that chart so far--well, first of all, do you understand what those numbers are and what they mean?

232 DR. SHIELDS:

Yes, I do.

233 MR. THOMPSON:

Okay. Would it be correct to characterize all of the numbers that are on the chart at this point as frequencies?

234 DR. SHIELDS:

Yes, it is.

235 MR. THOMPSON:

Okay. Now, if we put onto that chart numbers derived from Dr. Weir's computations, would those numbers be comparable as far as their meaning to the numbers that are already on there?

236 DR. SHIELDS:

No.

237 MR. CLARKE:

Objection. Vague.

238 THE COURT:

Overruled.

239 MR. THOMPSON:

And how would they differ?

240 DR. SHIELDS:

The difference stems from the column to the left of the frequency column. The column to the left says "Not excluded." And, therefore, it's the frequency of individuals who are not excluded. And if it's the frequency of individuals who are not excluded, the NRC's methodology is what gives you that proportion, that frequency. Dr. Weir's method gives you the frequency of pairs of individuals that would not be excluded.

241 MR. THOMPSON:

Or--just pairs or other common--

242 DR. SHIELDS:

Well, he's also done three's. But it doesn't do the frequency of individuals who would not be excluded, and that's what all of the other ones are.

243 MR. THOMPSON:

Okay. So if--are you saying that if we wanted the mixture numbers to be comparable in their meaning to the numbers that are already on there, we should present numbers done the NRC way?

244 DR. SHIELDS:

In my opinion, yes.

245 MR. THOMPSON:

Do you think it would be easy for people to understand the difference between the NRC numbers and Dr. Weir's numbers?

246 MR. CLARKE:

Objection. Calls for speculation.

247 THE COURT:

Overruled.

248 DR. SHIELDS:

I don't know.

249 MR. THOMPSON:

Okay. No further questions. Thank you, Dr. Shields.

250 THE COURT:

Mr. Clarke.

Temperature

procedural

Key Quotes (5)

Dr. Renee Shields
The genetic evidence of a mixture only allows one to say that one or more individuals contributed to that. It doesn't tell you who. If one assumes that one knows who produced a mixture, one is no longer doing a test of a hypothesis. One is just validating one's initial assumption.
Core methodological critique: Weir's approach assumes what it is supposed to test, making it circular rather than probative.
Dr. Renee Shields
Those two--with that set of words, contact and no contact, yes, I think they are [biased].
Direct testimony that Weir's likelihood ratio framing is biased against the defendant.
Dr. Renee Shields
You end up with instead of a number that gives someone a flavor for how likely it is that anybody might contribute to this mixed stain which is a single number, you have a set of numbers that can range from 1 in 7 to 1 in 17,000.
Illustrates the practical danger of Weir's method — the wide range of outputs can mislead jurors.
Dr. Renee Shields
I'm sure that many would [accept Weir's approach]. And do you think some would not? I'm sure that many would not. We have one of each here.
Candid acknowledgment of genuine scientific disagreement, while positioning herself as the opposing expert.
Dr. Renee Shields
It does not address the questions of the likelihood of getting a positive result evidence with a particular profile that's associated with errors of a variety of kinds, cross-contamination that can occur for a variety of reasons.
Expands the critique beyond statistics into lab error and contamination — themes central to the defense's broader DNA challenge.

Evidence (5)

People's 410
Chart showing DNA analysis results, displayed on the ELMO
discussed; Shields confirms computations comply with NRC recommendations for mixtures
Informal
NRC report 'DNA Technology and Forensic Science,' specifically page 59 on mixture statistics
discussed as authoritative standard; specific passage quoted and affirmed by witness
Informal
Prosecution chart 'Results of DNA Analysis, Bronco Automobile'
discussed; Shields argues mixture numbers computed by Weir's method would not be comparable to other frequency numbers already on the chart
Informal
Dr. Weir's most recent report (presented the previous day)
reviewed and criticized; Shields argues it departs from NRC methodology for mixtures
Defense next in order (CV)
Dr. Shields's curriculum vitae
introduced; submitted to court

Notable Exchanges (3)

Mr. ThompsonDr. Renee Shields
Shields reveals she was contacted to testify for the prosecution at Lisa Kahn's request before ultimately testifying for the defense — establishing her credibility as a non-partisan expert.
strategic
Mr. ThompsonDr. Renee Shields
Extended technical exchange on why Weir's likelihood ratio framing is inappropriate for mixture evidence, culminating in Shields stating the numbers are biased 'against' the defendant.
revealing
Mr. ThompsonDr. Renee Shields
Thompson attempts to elicit a clean answer about whether the scientific debate over mixture statistics constitutes a 'controversy'; Shields pushes back, saying the issue is 'emerging' rather than contested, as it hasn't been widely addressed yet.
nuanced

Light Moments (1)

Lance A. Ito
Confusion over whether Ito was asking Shields or Thompson about having a copy of exhibit 410, leading to a small flurry of clarifications before Ito just told Thompson to put it on the ELMO.

Objections

9 objections (0 sustained, 9 overruled)
Proceeding 6515 • 250 utterances • Prosecution witness
Criminal Trial
Department 103
⚖️ Start
📂 JUN 22, 1995 📄 Direct examination of William
JUN 22, 1995 KRT DvH TD